Ken Nagashima

427 total citations
18 papers, 369 citations indexed

About

Ken Nagashima is a scholar working on Pathology and Forensic Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Ken Nagashima has authored 18 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Ken Nagashima's work include Adenosine and Purinergic Signaling (6 papers), Cardiac Ischemia and Reperfusion (4 papers) and Chemotherapy-induced organ toxicity mitigation (3 papers). Ken Nagashima is often cited by papers focused on Adenosine and Purinergic Signaling (6 papers), Cardiac Ischemia and Reperfusion (4 papers) and Chemotherapy-induced organ toxicity mitigation (3 papers). Ken Nagashima collaborates with scholars based in Japan, Singapore and United States. Ken Nagashima's co-authors include Kozo Yao, Akira Karasawa, Hiroyuki Miki, Hideaki Kusaka, Yuzuru Matsuda, Satoshi Nakanishi, Yasuhiro Ina, Kenji Ohmori, Rie Sonoda and Tomofumi Santa and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Ken Nagashima

18 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Nagashima Japan 12 148 69 63 47 43 18 369
Hiroko Matsuda Japan 12 137 0.9× 73 1.1× 15 0.2× 75 1.6× 22 0.5× 41 362
Duncan Armstrong United Kingdom 13 279 1.9× 200 2.9× 45 0.7× 141 3.0× 40 0.9× 20 744
Darunee Hongwiset Thailand 7 165 1.1× 26 0.4× 171 2.7× 32 0.7× 30 0.7× 16 414
O. Heidenreich Germany 13 187 1.3× 65 0.9× 30 0.5× 60 1.3× 26 0.6× 75 561
Roberto P. Rosenkranz United States 12 188 1.3× 26 0.4× 23 0.4× 74 1.6× 70 1.6× 25 372
N. Wesley Norton United States 9 169 1.1× 58 0.8× 11 0.2× 52 1.1× 101 2.3× 11 482
Mary Carmen Vázquez Chile 9 154 1.0× 26 0.4× 58 0.9× 31 0.7× 33 0.8× 10 475
András Hrabák Hungary 14 148 1.0× 44 0.6× 13 0.2× 40 0.9× 40 0.9× 46 528
Mei‐Ling Chang Taiwan 10 129 0.9× 27 0.4× 38 0.6× 62 1.3× 19 0.4× 23 402
Yukio Yonetani Japan 13 159 1.1× 44 0.6× 8 0.1× 47 1.0× 23 0.5× 56 429

Countries citing papers authored by Ken Nagashima

Since Specialization
Citations

This map shows the geographic impact of Ken Nagashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Nagashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Nagashima more than expected).

Fields of papers citing papers by Ken Nagashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Nagashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Nagashima. The network helps show where Ken Nagashima may publish in the future.

Co-authorship network of co-authors of Ken Nagashima

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Nagashima. A scholar is included among the top collaborators of Ken Nagashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Nagashima. Ken Nagashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yao, Kozo, Ken Nagashima, & Hiroyuki Miki. (2006). Pharmacological, Pharmacokinetic, and Clinical Properties of Benidipine Hydrochloride, a Novel, Long-Acting Calcium Channel Blocker. Journal of Pharmacological Sciences. 100(4). 243–261. 73 indexed citations
2.
Yao, Kozo, et al.. (2003). Protective effects of benidipine on hydrogen peroxide-induced injury in rat isolated hearts. Journal of Pharmacy and Pharmacology. 55(1). 109–114. 38 indexed citations
3.
Kasprzak, K S, Yusaku Nakabeppu, Tatsuyuki Kakuma, et al.. (2001). Intracellular distribution of the antimutagenic enzyme MTH1 in the liver, kidney and testis of F344 ratsand its modulation by cadmium. Experimental and Toxicologic Pathology. 53(5). 325–335. 8 indexed citations
4.
5.
Tsunoda, Makoto, Tomofumi Santa, Yasuhiro Ina, et al.. (2000). New Approach for Measurement of Sympathetic Nervous Abnormality in Conscious, Spontaneously Hypertensive Rats.. The Japanese Journal of Pharmacology. 83(1). 39–45. 26 indexed citations
6.
Yao, Kozo, Hitoshi Sato, Yasuhiro Ina, et al.. (2000). Benidipine Inhibits Apoptosis During Ischaemic Acute Renal Failure in Rats. Journal of Pharmacy and Pharmacology. 52(5). 561–568. 13 indexed citations
7.
Imai, Kazuhiro, et al.. (1999). Attenuation of methylation of catecholamines and treatment with a coenzyme of catechol-O-methyltransferase in spontaneously hypertensive rats (SHR). Proceedings of the Japan Academy Series B. 75(7). 224–227. 17 indexed citations
8.
Sato, Hitoshi, Ken Nagashima, Hiroko Nomura, Akira Karasawa, & Satoshi Nishikawa. (1999). Protective Effects of KW-3902, an Adenosine A1-Receptor Antagonist, Against the Nephropathy Induced by Repeated Administration of Cisplatin in Rats.. Journal of Toxicologic Pathology. 12(1). 21–26. 2 indexed citations
9.
Sato, Hitoshi, et al.. (1999). Protective Effects of KW-3902, an Adenosine A1-Receptor Antagonist, Against Cisplatin-Induced Apoptosis in Rat Kidney.. Journal of Toxicologic Pathology. 12(3). 97–104. 2 indexed citations
10.
Nagashima, Ken & Akira Karasawa. (1996). Effects of KW-3902 (8-(Noradamantan-3-yl)-1,3-dipropylxanthine), an Adenosine A1-Receptor Antagonist, on Urinary Excretions of Various Electrolytes in Rats.. Biological and Pharmaceutical Bulletin. 19(7). 940–943. 8 indexed citations
11.
Nagashima, Ken & Akira Karasawa. (1996). Modulation of erythropoietin production by selective adenosine agonists and antagonists in normal and anemic rats. Life Sciences. 59(9). 761–771. 20 indexed citations
12.
Nomoto, Yuji, Ken Nagashima, Kozo Yao, et al.. (1996). Studies of Cardiotonic Agents. 8. Synthesis and Biological Activities of Optically Active 6-(4-(Benzylamino)-7-quinazolinyl)-4,5-dihydro-5-methyl- 3(2H)-pyridazinone (KF15232). Journal of Medicinal Chemistry. 39(1). 297–303. 29 indexed citations
13.
Nagashima, Ken, Hideaki Kusaka, & Akira Karasawa. (1995). Protective Effects of KW-3902, an Adenosine A1-Receptor Antagonist, against Cisplatin-Induced Acute Renal Failure in Rats. The Japanese Journal of Pharmacology. 67(4). 349–358. 30 indexed citations
14.
Kusaka, Hideaki, Ken Nagashima, & Akira Karasawa. (1995). Effects of KW-3902, an Adenosine A1-Receptor Antagonist, on Ascites Volume in Puromycin Aminonucleoside (PAN)-Induced Nephrotic Rats. The Japanese Journal of Pharmacology. 68(2). 213–216. 4 indexed citations
15.
Nagashima, Ken, Hideaki Kusaka, Kiyoshi Sato, & Akira Karasawa. (1994). Effects of KW-3902, a Novel Adenosine A1-Receptor Antagonist, on Cephaloridine-Induced Acute Renal Failure in Rats. The Japanese Journal of Pharmacology. 64(1). 9–18. 21 indexed citations
16.
Koike, Masamichi, Ken Nagashima, Kazuki Saito, et al.. (1991). Chemotactic peptide from ropalidian wasp as well as the authentic chemotactic tripeptide stimulates two distinct pathways in neutrophils, but the [LYS7] analog does only one of them. Biochemical and Biophysical Research Communications. 175(1). 165–172. 9 indexed citations
17.
Nagashima, Ken, Satoshi Nakanishi, & Yuzuru Matsuda. (1991). Inhibition of nerve growth factor‐induced neurite outgrowth of PC12 cells by a protein kinase inhibitor which does not permeate the cell membrane. FEBS Letters. 293(1-2). 119–123. 46 indexed citations
18.
Nagashima, Ken, Masamichi Koike, Kazuki Saito, et al.. (1990). Role of lysine residue at 7th position of wasp chemotactic peptides. Biochemical and Biophysical Research Communications. 168(2). 844–849. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroko Matsuda Breakdown of academic impact, for papers by Duncan Armstrong Breakdown of academic impact, for papers by Darunee Hongwiset Breakdown of academic impact, for papers by O. Heidenreich Breakdown of academic impact, for papers by Roberto P. Rosenkranz Breakdown of academic impact, for papers by N. Wesley Norton Breakdown of academic impact, for papers by Mary Carmen Vázquez Breakdown of academic impact, for papers by András Hrabák Breakdown of academic impact, for papers by Mei‐Ling Chang Breakdown of academic impact, for papers by Yukio Yonetani
Rankless by CCL
2026